GHK-Cu storage and stability start with the usual rules: keep the dry powder sealed, dry, dark and cold. The bigger risk is chemical rather than thermal. The copper is held by coordination bonds. Acid, chelators and reducing agents can break those bonds. The powder can look the same after that happens.
- GHK-Cu is a 1:1 copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, with copper accounting for roughly 16% of the mass of an idealized salt-free complex.
- Copper coordination depends on a deprotonated amide nitrogen, so acidic conditions dissociate the complex without any change in the appearance of the powder.
- Chelators, phosphate buffers and reducing agents such as ascorbate, DTT and TCEP all disrupt the complex.
- The blue color and its visible absorption band near 620 nm give a fast in-process check on complex integrity that peptide chromatography cannot provide.
- Peptide purity by RP-HPLC says nothing about copper stoichiometry, which requires a separate elemental assay.
- Letting a sealed vial reach room temperature before opening prevents condensation uptake into a hygroscopic cake.
What is in a GHK-Cu vial?
GHK is glycyl-L-histidyl-L-lysine, a tripeptide with a molecular formula of C14H24N6O4 and a monoisotopic mass near 340.2. GHK-Cu is that tripeptide holding a single copper(II) ion, which brings the formula weight of the 1:1 complex to roughly 402. Copper therefore accounts for about 16% of the mass of an idealized, salt-free, dry complex.
That number matters because the material sold under one name comes in more than one physical form. Some lots are the isolated complex, lyophilized as a blue to blue-violet cake. Some are GHK acetate supplied alongside a copper salt, with complexation left to a later step. Some are the peptide alone, mislabeled. The three behave differently in storage and they are not interchangeable in a protocol.
The first check costs nothing. Uncomplexed GHK is a white to off-white solid. The copper complex is blue. A vial labeled GHK-Cu containing a white powder is either not the complex or has lost its copper, and that observation belongs in the receiving record before anything else happens. The GHK-Cu product record states which form a given lot is supplied as.
- pH below about 5 — the amide reprotonates and the complex opens
- Chelators and phosphate — copper is pulled off or precipitated
- Reducing agents — copper(II) becomes copper(I) and radical chemistry starts
- Moisture from condensation — hygroscopic cake takes it up on opening
- Light and oxygen — photoreduction and histidine oxidation, with no visual cue
Why does coordination chemistry set the handling rules?
Copper(II) in GHK-Cu is not loosely associated with the peptide. It sits in a defined equatorial binding set: the terminal amine nitrogen of glycine, the deprotonated amide nitrogen of the Gly-His bond, and the imidazole nitrogen of histidine, forming two fused chelate rings. The fourth equatorial position is occupied by water, by a carboxylate, or in some conditions by a donor from a second molecule of the complex. Sigel and Martin's review of amide coordination in Chemical Reviews laid out why a peptide amide nitrogen becomes a competent copper donor only after it loses its proton, and that single fact explains most of what follows.
Because one of the three donors is a deprotonated amide, the complex is a creature of near-neutral pH. Acidify the solution and the amide reprotonates, the chelate opens, and you are left with protonated peptide and aquated copper ions sharing a tube. Push the pH high and hydroxide competes for the metal, with basic copper species dropping out of solution. The working window is narrow compared with what an ordinary tripeptide would tolerate.
Three classes of additive will strip or reorganize the metal regardless of pH. Chelators such as EDTA bind copper more tightly than the peptide does. Phosphate buffers can precipitate sparingly soluble copper phosphates. Reducing agents including ascorbate, DTT and TCEP convert copper(II) to copper(I), which the GHK binding set does not accommodate, and which in the presence of oxygen sets off radical chemistry that attacks the peptide.
How does GHK-Cu degrade, and what drives each route?
| Route | What drives it | How it shows | Practical control |
|---|---|---|---|
| Complex dissociation | pH below roughly 5, chelators, competing metals | Color fades toward pale blue or colorless | Dry, sealed storage away from acids and chelators |
| Metal-catalyzed oxidation | Copper redox cycling with oxygen and any reductant present | Histidine oxidation products on LC-MS, no visual cue | Minimal headspace, dark, cold, no reducing additives |
| Backbone hydrolysis | Water activity, temperature, extremes of pH | Fragment peaks by RP-HPLC | Keep the solid dry and sealed against desiccant |
| Copper hydroxide or phosphate precipitation | Alkaline drift, phosphate buffers | Faint blue haze or fine sediment | Inspect against a dark field |
| Photoreduction | Light, particularly in solution | Color change, then oxidation products | Amber glass or opaque secondary container |
| Moisture uptake | Hygroscopic cake, condensation on cold glass | Cake slumps, darkens or goes glassy | Equilibrate sealed vials to room temperature before opening |
Aggregation, which dominates the stability picture for larger and lipidated peptides, is barely relevant to a tripeptide. Surface adsorption is a smaller concern too, though copper will still find its way onto glass and onto some plastics. The compensating problem is redox chemistry, which a plain peptide does not have to think about at all. Copper is a competent single-electron catalyst, and the same coordination that defines the molecule keeps that catalyst sitting next to an oxidizable histidine.
What GHK-Cu storage conditions suit each physical state?
| State | Temperature | Light | Relative horizon | Why |
|---|---|---|---|---|
| Sealed powder, unopened | Minus 20 °C or below, desiccated | Dark | Longest | Hydrolysis and oxidation both slowed; water excluded |
| Sealed powder, working stock | 2 to 8 °C, desiccated | Dark | Shorter | Acceptable where the vial is consumed within a defined window |
| Powder in transit | Ambient | Dark, insulated | Days | The dry complex tolerates short excursions |
The horizons stay relative on purpose. A specific shelf life for a specific lot requires a stability study on that lot, in that closure, under those conditions, of the kind ICH Q1A(R2) describes for regulated products. Research suppliers rarely run one. Where a certificate carries a retest date without a supporting study, treat it as a convention rather than a measurement, and say so in the record.
Freezer temperature is the easy control to obsess over and not the one doing the heaviest work. Moisture accounts for most of the material that quietly stops being GHK-Cu.
How do you receive and hold a vial, step by step?
- Look at the color on receipt. The complex is blue; a white powder is either not the complex or has lost its copper. Write that in the receiving record before anything else happens.
- Store the sealed powder at minus 20 °C or below, desiccated and dark.
- Let a sealed vial reach room temperature before opening it, so condensation does not reach the hygroscopic cake.
Can color work as a quick check?
The blue of GHK-Cu comes from a copper d-d absorption band in the visible region, centered somewhere near 620 nm depending on the fourth ligand and the surroundings. There is also charge-transfer absorption in the ultraviolet. Neither band belongs to the peptide; they belong to the metal in that particular donor environment. Change the environment and the spectrum moves.
That makes color a free first check on the dry cake. It is no purity assay and should never be reported as one. What it does catch is the specific failure that RP-HPLC of the peptide component will miss entirely, because dissociated GHK still chromatographs perfectly well as GHK.
Visual inspection on receipt is the coarse version of the same check. Hold the sealed vial against a dark background. A blue to blue-violet cake is the complex; a pale or white one has lost its copper or never carried it.
How do you work out copper content?
The copper carried in a 50 mg vial, assuming a 1:1 salt-free complex with a formula weight of about 402 g/mol:
50 mg × 0.158 ≈ 7.9 mg Cu
That figure is documentation arithmetic, not a specification. Real lots carry counterions, residual solvent and water, so the measured copper fraction from an elemental assay will sit below the ideal value. How far below is itself information: a large shortfall points to underloaded complex or a peptide-plus-salt mixture, and a substantial excess points to free copper in the material. It covers laboratory measurement only.
What should the certificate and the record show?
A certificate of analysis for GHK-Cu that reports only peptide purity by RP-HPLC has answered half the question. Chromatographic purity describes the organic component. It says nothing about whether the copper is present, whether it is present at 1:1, or whether it is coordinated rather than sitting free in the powder. Acidic mobile phases containing trifluoroacetic acid will dissociate the complex on-column anyway, so most GHK-Cu chromatography is effectively an assay of GHK.
The documentation that closes the gap looks like this:
- Identity by mass spectrometry, where the copper isotope signature is diagnostic: 63Cu and 65Cu occur at roughly 69% and 31%, giving a two-peak pattern that free peptide cannot produce.
- Copper content by ICP-MS, ICP-OES or atomic absorption, reported as a percentage against the theoretical value. USP General Chapter <233> describes the validation expectations for these elemental procedures.
- Water content by Karl Fischer, since a hygroscopic cake makes every mass-based calculation approximate.
- Counterion identity and content, and residual solvents where synthesis warrants it.
For a received lot, the internal record should carry the source lot, the color seen on receipt, the storage temperature, the date each vial was first opened, and initials. When a result later looks wrong, this is the record that separates a chemistry problem from a material problem in about a minute. What a supplier is expected to provide is set out in the quality standard.
What is the regulatory position?
GHK is a naturally occurring tripeptide first characterized in human plasma in the 1970s, and its copper complex has been studied extensively since. There is no FDA-approved drug product containing GHK-Cu. The complex appears in cosmetic ingredient listings under the INCI name Copper Tripeptide-1; cosmetic ingredients in the United States are not subject to pre-market approval, and a cosmetic listing is not evidence of pharmaceutical quality, sterility or identity for any given lot.
Material supplied for laboratory work is characterized for identity and purity and nothing more. It is not manufactured under the quality systems that govern medicines, and no certificate of analysis for a research chemical constitutes a claim of fitness for any use in humans or animals.
Status verified August 26, 2026.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Bottom line
GHK-Cu holds its copper through coordination bonds that need near-neutral pH. Keep the powder sealed, dry, dark and cold, and keep acids, chelators, phosphate and reducing agents away from it. Use the blue color as a fast check, and look for a separate copper measurement on the certificate, because peptide purity by RP-HPLC says nothing about the metal.
What is GHK-Cu studied for?
Published research on GHK-Cu investigates the areas below, which is a different question from what GHK-Cu will do for anyone, a claim about a living system that nothing on this site is sold for.
What it is. A three-building-block peptide (glycine, histidine, lysine) joined to copper.
What the research looks at. A substantial body of cell-culture work on copper-peptide chemistry and the material that holds skin tissue together.
How it is thought to work. The peptide grips copper tightly, and the copper-carrying form is what the research is about. Its blue color comes from that copper, not from the peptide. Published work covers the copper chemistry and the biology of the material between skin cells, in culture.
What is not established. No approved drug product. The copper-carrying form and the bare peptide are different chemicals with different stability, and a certificate should make clear which one is in the vial.
The full record, including the certificate for the lot in stock, is on the GHK-Cu product page.
Common questions
How should GHK-Cu be stored?
The cake in my vial is white rather than blue. What does that mean?
Does HPLC purity on the certificate tell me the copper is there?
How long does lyophilized GHK-Cu last?
Is a visible-spectrum reading a substitute for a purity assay?
Published certificates for GHK-Cu
Every figure below is read from a report the laboratory issued for that lot; each page carries the PDF and the lab's own verification link.
More handling guides
Sources
- Sigel and Martin, Chemical Reviews, 1982. Review of the coordinating properties of the amide bond; establishes that peptide amide nitrogen binds copper(II) only after deprotonation, which underlies the pH sensitivity described here.
- Pickart and Margolina, International Journal of Molecular Sciences, 2018. Review of GHK and its copper complex; supports the composition, the 1:1 copper stoichiometry and the general chemistry of the complex.
- USP General Chapter <233>, Elemental Impurities — Procedures. Defines validated ICP-MS and ICP-OES approaches for elemental determination; the reference standard for how a copper content figure on a certificate should have been generated.
- ICH Q1A(R2), Stability Testing of New Drug Substances and Products. Establishes what a defensible shelf life or retest date requires, and by extension why an unsupported storage figure on a research certificate is a convention rather than a measurement.
